LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LG Life Science LTD (068870) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013613
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medicine, fine chem, facial aesthetics, viscosupplements, products for hormones and fertility treatment. LGLS offers intermax gamma, intermax alpha, degenerative arthritis treatment, and others. The company’s target therapeutic areas include infectious disease, metabolic disease, urology, oncology, musculoskeletal, endocrinology, infertility, molecular diagnostics and others. It operates through its research center and plant, located in Korea. The company has operational presence in India, Poland, China and Jordan. LGLS is headquartered in Seoul, South Korea.

LG Life Science LTD (068870) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
LG Life Science LTD, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
Licensing Agreements 16
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD – Key Competitors 21
LG Life Science LTD – Key Employees 22
LG Life Science LTD – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
LG Life Science LTD, Pharmaceuticals & Healthcare, Key Facts, 2015 2
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD, Key Competitors 21
LG Life Science LTD, Key Employees 22
LG Life Science LTD, Other Locations 23
LG Life Science LTD, Subsidiaries 23

★海外企業調査レポート[LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CymaBay Therapeutics Inc (CBAY):企業の財務・戦略的SWOT分析
    CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Heidelberg Pharma AG (WL6)-製薬・医療分野:企業M&A・提携分析
    Summary Heidelberg Pharma AG(Heidelberg Pharma) formerly known as Wilex AG is a biopharmaceutical company with a focus on cancer. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. It develops products based on and small mo …
  • Tien Phong Plastic (NTP):企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesoph …
  • AIG Japan Holdings Kabushiki Kaisha:企業の戦略・SWOT・財務分析
    AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Invicta Holdings Limited:企業の戦略・SWOT・財務分析
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nuance Communications, Inc. (NUAN)-医療機器分野:企業M&A・提携分析
    Summary Nuance Communications, Inc. (Nuance) is a provider of speech and imaging solutions. It offers solutions such as automated speech recognition, dialog management, capabilities for natural language understanding, optical character recognition (OCR), domain knowledge and implementation capabilit …
  • Student Transportation Inc.:企業の戦略・SWOT・財務情報
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Care UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Care UK Ltd (Care UK) is a healthcare service provider that offers clinical and social care services. The company’s healthcare services include treatment centres, General Practitioner(GP) practices, NHS walk-in centres, GP out-of-hours, prison health services, clinical assessment, diagnostic …
  • American Financial Group, Inc.:企業の戦略・SWOT・財務情報
    American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • TOTAL S.A.:企業のM&A・事業提携・投資動向
    TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • Hill-Rom Holdings Inc (HRC)-医療機器分野:企業M&A・提携分析
    Summary Hill-Rom Holdings Inc (Hill-Rom) is a medical technology company that offers patient support systems, surgical solutions and other front line care products. The company’s major products and services include patient care systems; safe mobility and handling solutions; non-invasive therapeutic …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Starbreeze AB (STAR B):企業の財務・戦略的SWOT分析
    Summary Starbreeze AB (Starbreeze) is a game development company that creates, publishes and distributes entertainment products and games. The company’s published games include the outforce, enclave, knights of the temple, syndicate, the chronicles of riddick, knights of the temple, enclave, escapes …
  • Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix …
  • Adpo Group NV:企業の戦略的SWOT分析
    Adpo Group NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆